{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:44:31Z","timestamp":1773287071300,"version":"3.50.1"},"reference-count":90,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The pandemic of COVID-19 has presented new challenges to hospital personnel providing care for infected patients with diabetes who represent more than 20% of critically ill patients in intensive care units. Appropriate glycemic management contributes to a reduction in adverse clinical outcomes in acute illness but also requires intensive patient interactions for bedside glucose monitoring, intravenous and subcutaneous insulin administration, as well as rapid intervention for hypoglycemia events. These tasks are required at a time when minimizing patient interactions is recommended as a way of avoiding prolonged exposure to COVID-19 by health care personnel who often practice in settings with limited supplies of personal protective equipment. The purpose of this manuscript is to provide guidance for clinicians for reconciling recommended standards of care for infected hospitalized patients with diabetes while also addressing the daily realities of an overwhelmed health care system in many areas of the country. The use of modified protocols for insulin administration, bedside glucose monitoring, and medications such as glucocorticoids and hydroxychloroquine that may affect glycemic control are discussed. Continuous glucose monitoring systems have been proposed as an option for reducing time spent with patients, but there are important issues that need to be addressed if these are used in hospitalized patients. On-site and remote glucose management teams have potential to provide guidance in areas where there are shortages of personnel who have expertise in inpatient glycemic management.<\/jats:p>","DOI":"10.1210\/clinem\/dgaa342","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T05:18:58Z","timestamp":1591334338000},"page":"3076-3087","source":"Crossref","is-referenced-by-count":68,"title":["A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7131-8903","authenticated-orcid":false,"given":"Mary","family":"Korytkowski","sequence":"first","affiliation":[{"name":"University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie","family":"Antinori-Lent","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center Shadyside Hospital, Omaha, NE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andjela","family":"Drincic","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, NE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irl B","family":"Hirsch","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-9783","authenticated-orcid":false,"given":"Marie E","family":"McDonnell","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Rushakoff","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4198-1055","authenticated-orcid":false,"given":"Ranganath","family":"Muniyappa","sequence":"additional","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"2020091813243555500_CIT0001","first-page":"458","author":"Garg","year":"2020"},{"key":"2020091813243555500_CIT0002","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York City","author":"Goyal","year":"2020","journal-title":"N Engl J Med"},{"key":"2020091813243555500_CIT0003","first-page":"dc200723","article-title":"Outcomes in patients with hyperglycemia affected by Covid-19: can we do more on glycemic control?","author":"Sardu","year":"2020","journal-title":"Diabetes Care"},{"key":"2020091813243555500_CIT0004","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"2020091813243555500_CIT0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/dc09-9029","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"32","author":"Moghissi","year":"2009","journal-title":"Diabetes Care."},{"issue":"1","key":"2020091813243555500_CIT0006","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2020091813243555500_CIT0007","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med."},{"issue":"2","key":"2020091813243555500_CIT0008","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care."},{"issue":"19","key":"2020091813243555500_CIT0009","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med."},{"key":"2020091813243555500_CIT0010","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"N-SS. Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"2020091813243555500_CIT0011","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.2337\/dc20-S015","article-title":"Diabetes care in the hospital: standards of medical care in diabetes - 2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care."},{"issue":"5","key":"2020091813243555500_CIT0012","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/1932296815590827","article-title":"Patient self-management of diabetes care in the inpatient setting: pro","volume":"9","author":"Mabrey","year":"2015","journal-title":"J Diabetes Sci Technol."},{"issue":"5","key":"2020091813243555500_CIT0013","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/1932296815586581","article-title":"Patient self-management of diabetes care in the inpatient setting: con","volume":"9","author":"Shah","year":"2015","journal-title":"J Diabetes Sci Technol."},{"issue":"8","key":"2020091813243555500_CIT0014","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/dme.13677","article-title":"Self-management of diabetes in hospital: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group","volume":"35","author":"Flanagan","year":"2018","journal-title":"Diabet Med."},{"key":"2020091813243555500_CIT0015","doi-asserted-by":"crossref","first-page":"154224","DOI":"10.1016\/j.metabol.2020.154224","article-title":"COVID-19 in patients with diabetes: risk factors that increase morbidity","author":"Klonoff","year":"2020","journal-title":"Metabolism"},{"key":"2020091813243555500_CIT0016","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa148","article-title":"Our Response to COVID-19 as endocrinologists and diabetologists","volume":"105","author":"Kaiser","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020091813243555500_CIT0017","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1553-2712.2011.01014.x","article-title":"Prevalence of undiagnosed and suboptimally controlled diabetes by point-of-care HbA1C in unselected emergency department patients","volume":"18","author":"Menchine","year":"2011","journal-title":"Acad Emerg Med."},{"key":"2020091813243555500_CIT0018","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz087","article-title":"Results of a study comparing glycated albumin to other glycemic indices","volume":"105","author":"Desouza","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020091813243555500_CIT0019","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1932296814567227","article-title":"Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes","volume":"9","author":"Danese","year":"2015","journal-title":"J Diabetes Sci Technol."},{"issue":"4","key":"2020091813243555500_CIT0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4158\/EP.12.4.358","article-title":"Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients","volume":"12","author":"Donihi","year":"2006","journal-title":"Endocr Pract."},{"issue":"4","key":"2020091813243555500_CIT0021","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2337\/dc08-1436","article-title":"Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial","volume":"32","author":"Korytkowski","year":"2009","journal-title":"Diabetes Care."},{"issue":"1","key":"2020091813243555500_CIT0022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41387-018-0053-x","article-title":"Very high-protein and low-carbohydrate enteral nutrition formula and plasma glucose control in adults with type 2 diabetes mellitus: a randomized crossover trial","volume":"8","author":"Huhmann","year":"2018","journal-title":"Nutr Diabetes."},{"issue":"8","key":"2020091813243555500_CIT0023","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11892-017-0882-3","article-title":"Nutrition and hyperglycemia management in the inpatient setting (meals on demand, parenteral, or enteral nutrition)","volume":"17","author":"Drincic","year":"2017","journal-title":"Curr Diab Rep."},{"issue":"4","key":"2020091813243555500_CIT0024","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/qshc.2008.027441","article-title":"Menu selection, glycaemic control and satisfaction with standard and patient-controlled consistent carbohydrate meal plans in hospitalised patients with diabetes","volume":"19","author":"Curll","year":"2010","journal-title":"Qual Saf Health Care."},{"issue":"4","key":"2020091813243555500_CIT0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4158\/EP10354.OR","article-title":"Long-acting subcutaneously administered insulin for glycemic control immediately after cardiac surgery","volume":"17","author":"Aggarwal","year":"2011","journal-title":"Endocr Pract."},{"issue":"9","key":"2020091813243555500_CIT0026","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/dc07-0295","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial)","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care."},{"issue":"6","key":"2020091813243555500_CIT0027","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0884533611420727","article-title":"Comparison of 70\/30 biphasic insulin with glargine\/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy","volume":"26","author":"Hsia","year":"2011","journal-title":"Nutr Clin Pract."},{"issue":"9","key":"2020091813243555500_CIT0028","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2012-1244","article-title":"Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia","volume":"97","author":"Hsia","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020091813243555500_CIT0029","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/jc.2008-0761","article-title":"Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans","volume":"94","author":"van der Crabben","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2020091813243555500_CIT0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11892-012-0339-7","article-title":"Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes","volume":"13","author":"Baldwin","year":"2013","journal-title":"Curr Diab Rep."},{"issue":"1","key":"2020091813243555500_CIT0031","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/0886022X.2020.1756323","article-title":"Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis","volume":"42","author":"Ali","year":"2020","journal-title":"Ren Fail."},{"issue":"10","key":"2020091813243555500_CIT0032","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2337\/dc12-0578","article-title":"A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency","volume":"35","author":"Baldwin","year":"2012","journal-title":"Diabetes Care."},{"issue":"5","key":"2020091813243555500_CIT0033","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1464-5491.2000.00289.x","article-title":"Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus","volume":"17","author":"Brunner","year":"2000","journal-title":"Diabet Med."},{"issue":"3","key":"2020091813243555500_CIT0034","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/dme.13525","article-title":"Optimal prandial timing of bolus insulin in diabetes management: a review","volume":"35","author":"Slattery","year":"2018","journal-title":"Diabet Med."},{"issue":"11","key":"2020091813243555500_CIT0035","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.2337\/dc13-0121","article-title":"Prandial insulin dosing using the carbohydrate counting technique in hospitalized patients with type 2 diabetes","volume":"36","author":"Dungan","year":"2013","journal-title":"Diabetes Care."},{"issue":"6","key":"2020091813243555500_CIT0036","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1210\/jc.2013-4519","article-title":"Glucose turnover after replacement of usual therapy by insulin in insulin-naive type 2 diabetes subjects","volume":"99","author":"Thabit","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2020091813243555500_CIT0037","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11892-019-1184-8","article-title":"Debate on insulin vs non-insulin use in the hospital setting-is it time to revise the guidelines for the management of inpatient diabetes?","volume":"19","author":"Pasquel","year":"2019","journal-title":"Curr Diab Rep."},{"issue":"4","key":"2020091813243555500_CIT0038","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/dom.13587","article-title":"Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial","volume":"21","author":"Vellanki","year":"2019","journal-title":"Diabetes Obes Metab."},{"issue":"3-4","key":"2020091813243555500_CIT0039","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/07853890.2019.1613672","article-title":"Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study","volume":"51","author":"P\u00e9rez-Belmonte","year":"2019","journal-title":"Ann Med."},{"issue":"11","key":"2020091813243555500_CIT0040","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.2337\/dc13-0277","article-title":"Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care."},{"issue":"2","key":"2020091813243555500_CIT0041","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","article-title":"Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial","volume":"5","author":"Pasquel","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2020091813243555500_CIT0042","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa011","article-title":"Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications","author":"Drucker","year":"2020","journal-title":"Endocr Rev"},{"key":"2020091813243555500_CIT0043","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00124.2020","article-title":"COVID-19 pandemic, corona viruses, and diabetes mellitus","author":"Muniyappa","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020091813243555500_CIT0044","doi-asserted-by":"crossref","first-page":"108125","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and diabetes: Can DPP4 inhibition play a role?","volume":"162","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"14","key":"2020091813243555500_CIT0045","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med."},{"issue":"11","key":"2020091813243555500_CIT0046","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/M15-2568","article-title":"Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study","volume":"164","author":"Toh","year":"2016","journal-title":"Ann Intern Med."},{"issue":"7","key":"2020091813243555500_CIT0047","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/j.1875-9114.2011.01088.x","article-title":"Hypoglycemia in hospitalized patients treated with sulfonylureas","volume":"32","author":"Deusenberry","year":"2012","journal-title":"Pharmacotherapy."},{"key":"2020091813243555500_CIT0048","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2337\/dc19-0923","article-title":"Inzucchi SE. reports of lactic acidosis attributed to metformin, 2015\u20132018","volume":"43","author":"Flory","year":"2020","journal-title":"Diabetes Care."},{"issue":"7","key":"2020091813243555500_CIT0049","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.2337\/dc12-2233","article-title":"Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care."},{"issue":"9","key":"2020091813243555500_CIT0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11892-018-1038-9","article-title":"SGLT2 inhibitors and cardiovascular outcomes: current perspectives and future potentials","volume":"18","author":"Jia","year":"2018","journal-title":"Curr Diab Rep."},{"key":"2020091813243555500_CIT0051","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa200","article-title":"Evolving evidence of diabetic ketoacidosis in patients taking sodium glucose cotransporter 2 inhibitors","author":"Fleming","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2020091813243555500_CIT0052","doi-asserted-by":"crossref","DOI":"10.1111\/jcpt.13107","article-title":"The use of sodium-glucose co-transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?","author":"Koufakis","year":"2020","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"2020091813243555500_CIT0053","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/ACO.0000000000000674","article-title":"Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications","volume":"32","author":"Bardia","year":"2019","journal-title":"Curr Opin Anaesthesiol."},{"issue":"8","key":"2020091813243555500_CIT0054","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/dc17-1960","article-title":"Investigation of the accuracy of 18 marketed blood glucose monitors","volume":"41","author":"Klonoff","year":"2018","journal-title":"Diabetes Care."},{"issue":"1","key":"2020091813243555500_CIT0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2337\/dci19-0054","article-title":"Putting continuous glucose monitoring to work for people with type 1 diabetes","volume":"43","author":"Hood","year":"2020","journal-title":"Diabetes Care."},{"issue":"5","key":"2020091813243555500_CIT0056","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2337\/dc19-1459","article-title":"Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials","volume":"43","author":"Maiorino","year":"2020","journal-title":"Diabetes Care."},{"key":"2020091813243555500_CIT0057"},{"issue":"1","key":"2020091813243555500_CIT0058","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1932296817748964","article-title":"The effect of continuous glucose monitoring in preventing inpatient hypoglycemia in general wards: the glucose telemetry system","volume":"12","author":"Spanakis","year":"2018","journal-title":"J Diabetes Sci Technol."},{"key":"2020091813243555500_CIT0059","article-title":"Continuous glucose monitoring in general wards for prevention of hypoglycemia: results from the glucose telemetry system pilot study","author":"Singh","year":"2019","journal-title":"J Diabetes Sci Technol."},{"key":"2020091813243555500_CIT0060","article-title":"A pilot study of the feasibility and accuracy of inpatient continuous glucose monitoring","volume":"43:dc200670","author":"Nair","year":"2020","journal-title":"Diabetes Care."},{"issue":"5","key":"2020091813243555500_CIT0061","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/1932296817706151","article-title":"Consensus statement on inpatient use of continuous glucose monitoring","volume":"11","author":"Wallia","year":"2017","journal-title":"J Diabetes Sci Technol."},{"issue":"8","key":"2020091813243555500_CIT0062","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2337\/dci18-0002","article-title":"Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital","volume":"41","author":"Umpierrez","year":"2018","journal-title":"Diabetes Care."},{"issue":"5","key":"2020091813243555500_CIT0063","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/1932296816660326","article-title":"Diabetes educators: perceived experiences, supports and barriers to use of common diabetes-related technologies","volume":"10","author":"James","year":"2016","journal-title":"J Diabetes Sci Technol."},{"issue":"9","key":"2020091813243555500_CIT0064","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4239\/wjd.v10.i9.473","article-title":"Future technology-enabled care for diabetes and hyperglycemia in the hospital setting","volume":"10","author":"Montero","year":"2019","journal-title":"World J Diabetes."},{"issue":"5","key":"2020091813243555500_CIT0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4158\/EP09063.ORR","article-title":"Patient outcomes after implementation of a protocol for inpatient insulin pump therapy","volume":"15","author":"Noschese","year":"2009","journal-title":"Endocr Pract."},{"key":"2020091813243555500_CIT0066","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/193229680800200605","article-title":"Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: a review of one institution\u2019s experience","volume":"2","author":"Leonardi","year":"2008","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"2020091813243555500_CIT0067","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11892-018-1056-7","article-title":"An overview of safety issues on use of insulin pumps and continuous glucose monitoring systems in the hospital","volume":"18","author":"Thompson","year":"2018","journal-title":"Curr Diab Rep."},{"issue":"4","key":"2020091813243555500_CIT0068","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1177\/1932296818769933","article-title":"Consensus statement on use of continuous subcutaneous insulin infusion therapy in the hospital","volume":"12","author":"Thompson","year":"2018","journal-title":"J Diabetes Sci Technol."},{"key":"2020091813243555500_CIT0069"},{"key":"2020091813243555500_CIT0070","doi-asserted-by":"crossref","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) study: rationale and design","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"2020091813243555500_CIT0071","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12020-016-1220-2","article-title":"Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies","volume":"56","author":"Healy","year":"2017","journal-title":"Endocrine."},{"issue":"2","key":"2020091813243555500_CIT0072","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3810\/hp.2014.04.1100","article-title":"Insulin requirements in non-critically ill hospitalized patients with diabetes and steroid-induced hyperglycemia","volume":"42","author":"Spanakis","year":"2014","journal-title":"Hosp Pract (1995)."},{"issue":"10229","key":"2020091813243555500_CIT0073","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"issue":"2","key":"2020091813243555500_CIT0074","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4158\/EP15818.OR","article-title":"Hospital insulin protocol aims for glucose control in glucocorticoid-induced hyperglycemia","volume":"22","author":"Grommesh","year":"2016","journal-title":"Endocr Pract."},{"issue":"2","key":"2020091813243555500_CIT0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4158\/EP151101.CO","article-title":"Use of nph insulin for glucocorticoid-induced hyperglycemia","volume":"22","author":"Low Wang","year":"2016","journal-title":"Endocr Pract."},{"issue":"3","key":"2020091813243555500_CIT0076","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jhm.874","article-title":"Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes","volume":"6","author":"Seggelke","year":"2011","journal-title":"J Hosp Med."},{"issue":"4","key":"2020091813243555500_CIT0077","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jhm.646","article-title":"Safety and efficacy of continuous insulin infusion in noncritical care settings","volume":"5","author":"Smiley","year":"2010","journal-title":"J Hosp Med."},{"issue":"4","key":"2020091813243555500_CIT0078","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2146\/ajhp060014","article-title":"Implementing an intravenous insulin infusion protocol in the intensive care unit","volume":"64","author":"Rea","year":"2007","journal-title":"Am J Health Syst Pharm."},{"issue":"10","key":"2020091813243555500_CIT0079","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1007\/s00125-015-3689-2","article-title":"Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial","volume":"58","author":"Wasko","year":"2015","journal-title":"Diabetologia."},{"key":"2020091813243555500_CIT0080","doi-asserted-by":"crossref","first-page":"5214751","DOI":"10.1155\/2020\/5214751","article-title":"Potential effect of hydroxychloroquine in diabetes mellitus: a systematic review on preclinical and clinical trial studies","volume":"2020","author":"Wondafrash","year":"2020","journal-title":"J Diabetes Res."},{"issue":"4","key":"2020091813243555500_CIT0081","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.dsx.2020.04.014","article-title":"Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: what should we have in mind during the COVID-19 pandemic?","volume":"14","author":"Bareti\u0107","year":"2020","journal-title":"Diabetes Metab Syndr."},{"issue":"9","key":"2020091813243555500_CIT0082","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11892-017-0896-x","article-title":"Remote Monitoring and consultation of inpatient populations with diabetes","volume":"17","author":"Rushakoff","year":"2017","journal-title":"Curr Diab Rep."},{"issue":"9","key":"2020091813243555500_CIT0083","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/M16-1413","article-title":"Association between a virtual glucose management service and glycemic control in hospitalized adult patients: an observational study","volume":"166","author":"Rushakoff","year":"2017","journal-title":"Ann Intern Med."},{"issue":"3","key":"2020091813243555500_CIT0084","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11892-018-0972-x","article-title":"Common models used for inpatient diabetes management","volume":"18","author":"Drincic","year":"2018","journal-title":"Curr Diab Rep."},{"issue":"7","key":"2020091813243555500_CIT0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11892-017-0876-1","article-title":"Practical recommendations for transitioning patients with type 2 diabetes from hospital to home","volume":"17","author":"Donihi","year":"2017","journal-title":"Curr Diab Rep."},{"issue":"6","key":"2020091813243555500_CIT0086","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/0145721714551993","article-title":"Telemedicine for Reach, Education, Access, and Treatment (TREAT): linking telemedicine with diabetes self-management education to improve care in rural communities","volume":"40","author":"Siminerio","year":"2014","journal-title":"Diabetes Educ."},{"issue":"5","key":"2020091813243555500_CIT0087","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/pop.2017.0175","article-title":"Remote patient monitoring and clinical outcomes for postdischarge patients with type 2 diabetes","volume":"21","author":"Michaud","year":"2018","journal-title":"Popul Health Manag."},{"issue":"6","key":"2020091813243555500_CIT0088","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2337\/dc18-1631","article-title":"Nonadherence to insulin therapy detected by bluetooth-enabled pen cap is associated with poor glycemic control","volume":"42","author":"Munshi","year":"2019","journal-title":"Diabetes Care."},{"issue":"5 Suppl","key":"2020091813243555500_CIT0089","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jhm.356","article-title":"Society of hospital medicine glycemic control task force summary: practical recommendations for assessing the impact of glycemic control efforts","volume":"3","author":"Schnipper","year":"2008","journal-title":"J Hosp Med."},{"issue":"6","key":"2020091813243555500_CIT0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4158\/EP.12.6.641","article-title":"Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia","volume":"12","author":"Schmeltz","year":"2006","journal-title":"Endocr Pract."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa342\/33345711\/dgaa342.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/105\/9\/3076\/33770381\/dgaa342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/105\/9\/3076\/33770381\/dgaa342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T17:26:40Z","timestamp":1600450000000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/9\/3076\/5851514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa342","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,6,4]]}}}